rethinkPeptides Search
Menu
Home / Research library
Study breakdown

Alpha-MSH and Its Fragment KPV Kill Bacteria and Fungi as Part of the Body's Innate Defense

RPEP-005862000Catania, A; Cutuli, M; Garofalo, L; Carlin, A; Airaghi, L; Barcellini, W; Lipton, J M
In VitroPreliminary evidence
The takeaway

Alpha-MSH and its C-terminal tripeptide KPV showed antimicrobial activity against Staphylococcus aureus, Candida albicans, and E. coli, revealing a new defense role for this anti-inflammatory peptide.

Dual function

Alpha-MSH/KPV is both antimicrobial (kills Staph, Candida, E. coli) AND anti-inflammatory — uniquely suited for barrier organ defense

What the researchers found

Alpha-MSH and its C-terminal tripeptide fragment KPV demonstrated direct antimicrobial activity against S. aureus, C. albicans, and E. coli, establishing a dual anti-inflammatory/antimicrobial function for this neuropeptide.

Why it matters

A peptide that is simultaneously anti-inflammatory AND antimicrobial is uniquely suited for protecting barrier organs like skin and gut, where infection and inflammation often coexist.

How the study worked

In-vitro antimicrobial testing of alpha-MSH (1-13) and KPV (11-13) against S. aureus, C. albicans, and E. coli using standard microbiological assays.

What this study cannot tell us

In-vitro antimicrobial testing. Concentrations achieving antimicrobial effects may differ from physiological levels. Mechanism of antimicrobial action not fully characterized.

How to read the evidence

Preliminary in-vitro evidence demonstrating direct antimicrobial activity for a peptide already known for anti-inflammatory effects.

When this study was published

Published in 2000. KPV has since gained significant interest as a therapeutic peptide for gut inflammation (IBD) and skin conditions.

The bigger picture

The body's innate defense at barrier surfaces needs to fight microbes while controlling inflammation. Alpha-MSH/KPV does both simultaneously, representing an elegant evolutionary solution to the challenge of barrier immunity.

Questions still open

  • Is alpha-MSH/KPV antimicrobial activity sufficient at physiological concentrations?
  • Could KPV be developed as a topical antimicrobial/anti-inflammatory agent?
  • Does alpha-MSH deficiency increase susceptibility to skin or gut infections?

Common questions

What is KPV?
KPV is just three amino acids (Lys-Pro-Val) from the end of alpha-MSH. Despite being tiny, it retains both the anti-inflammatory and antimicrobial properties of the full peptide, making it an attractive therapeutic candidate.
How can such a small peptide kill bacteria?
Many antimicrobial peptides work by disrupting bacterial membranes. KPV's positively charged structure allows it to interact with and damage the negatively charged bacterial cell surface, a fundamental antimicrobial mechanism.

Read the original research

The neuropeptide alpha-MSH in host defense.

Annals of the New York Academy of Sciences, 917, 227-31

View on PubMed ↗

Citation

Catania, A; Cutuli, M; Garofalo, L; Carlin, A; Airaghi, L; Barcellini, W; Lipton, J M. (2000). The neuropeptide alpha-MSH in host defense.. Annals of the New York Academy of Sciences, 917, 227-31.